A GCH1 haplotype and risk of neural tube defects in the National Birth Defects Prevention Study
- PMID: 23059057
- PMCID: PMC3704723
- DOI: 10.1016/j.ymgme.2012.09.020
A GCH1 haplotype and risk of neural tube defects in the National Birth Defects Prevention Study
Abstract
Tetrahydrobiopterin (BH(4)) is an essential cofactor and an important cellular antioxidant. BH(4) deficiency has been associated with diseases whose etiologies stem from excessive oxidative stress. GTP cyclohydrolase I (GCH1) catalyzes the first and rate-limiting step of de novo BH(4) synthesis. A 3-SNP haplotype in GCH1 (rs8007267, rs3783641, and rs10483639) is known to modulate GCH1 gene expression levels and has been suggested as a major determinant of plasma BH(4) bioavailability. As plasma BH(4) bioavailability has been suggested as a mechanism of neural tube defect (NTD) teratogenesis, we evaluated the association between this GCH1 haplotype and the risk of NTDs. Samples were obtained from 760 NTD case-parent triads included in the National Birth Defects Prevention Study (NBDPS). The three SNPs were genotyped using TaqMan® SNP assays. An extension of the log-linear model was used to assess the association between NTDs and both offspring and maternal haplotypes. Offspring carrying two copies of haplotype C-T-C had a significantly increased NTD risk (risk ratio [RR]=3.40, 95% confidence interval [CI]: 1.02-11.50), after adjusting for the effect of the maternal haplotype. Additionally, mothers carrying two copies of haplotype C-T-C had a significantly increased risk of having an NTD-affected offspring (RR=3.46, 95% CI: 1.05-11.00), after adjusting for the effect of the offspring haplotype. These results suggest offspring and maternal variation in the GCH1 gene and altered BH(4) biosynthesis may contribute to NTD risk.
Published by Elsevier Inc.
Figures
References
-
- Traister A, Abashidze S, Gold V, Plachta N, Karchovsky E, Patel K, Weil M. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev Dyn. 2002;225:271–276. - PubMed
-
- Nachmany A, Gold V, Tsur A, Arad D, Weil M. Neural tube closure depends on nitric oxide synthase activity. J Neurochem. 2006;96:247–253. - PubMed
-
- Gesierich A, Niroomand F, Tiefenbacher CP. Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism. Basic Res Cardiol. 2003;98:69–75. - PubMed
-
- Antoniades C, Shirodaria C, Van Assche T, Cunnington C, Tegeder I, Lotsch J, Guzik TJ, Leeson P, Diesch J, Tousoulis D, Stefanadis C, Costigan M, Woolf CJ, Alp NJ, Channon KM. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function. J Am Coll Cardiol. 2008;52:158–165. - PMC - PubMed
-
- Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269–1277. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- FOA DD09-001/DD/NCBDD CDC HHS/United States
- NS 076465/NS/NINDS NIH HHS/United States
- R21 HD 058912/HD/NICHD NIH HHS/United States
- U50/CCU925286/PHS HHS/United States
- PA 02081/PHS HHS/United States
- U01/DD000494/DD/NCBDD CDC HHS/United States
- P01 HD067244/HD/NICHD NIH HHS/United States
- R01 NS076465/NS/NINDS NIH HHS/United States
- HD 067244/HD/NICHD NIH HHS/United States
- U01 DD000494/DD/NCBDD CDC HHS/United States
- PA 96043/PHS HHS/United States
- R21 HD058912/HD/NICHD NIH HHS/United States
- R01 NS 050249/NS/NINDS NIH HHS/United States
- R01 NS050249/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
